25 September 2025 Cedars-Sinai Medical Center based in Los Angeles has been awarded $5M by Advanced Research Projects Agency for Health (ARPA-H) to develop a human-based AI-driven KronosRx platform for improved prediction of adverse drug effects. The ARPA-H Computational ADME-Tox and Physiology Analysis for Safer Therapeutics (CATALYST) program aims to revolutionize preclinical drug safety prediction by facilitating the development of next gen in vitro and in silico model